Approved indications
IV rifampin is used, usually with other drugs, to treat active tuberculosis and other serious infections due to susceptible bacteria (for example some staphylococcal infections, meningitis prophylaxis when oral dosing is not possible, or other severe systemic infections), especially when patients cannot take medicines by mouth.

Off-label uses
Clinicians may use IV rifampin off label as part of combination therapy for prosthetic joint infections, infective endocarditis, and other hardware-associated staphylococcal infections; evidence comes mainly from clinical experience, observational studies, and some trials supporting improved bacterial clearance when combined with other agents.

Efficacy expectations
For tuberculosis, fever and systemic symptoms may start to improve within 1–2 weeks, though full treatment usually takes several months with a multidrug regimen; for other severe infections, clinical improvement is often seen within days if the bacteria are susceptible and source control is achieved. Rifampin is considered one of the most potent first-line anti-tuberculosis drugs and, when used correctly with companion drugs, shortens treatment duration and reduces relapse risk compared with regimens without rifampin.

Typical dosing and how it is given
For adults, IV rifampin is commonly given at about 10 mg/kg once daily, not usually exceeding 600 mg per day for tuberculosis and many other infections; pediatric doses are weight-based, often 10–20 mg/kg once daily up to a maximum daily dose determined by the prescriber. It is administered as a diluted intravenous infusion over a set time (for example 30 minutes or longer) by trained staff or, in some cases, by patients or caregivers taught to use home infusion equipment.

Special dosing instructions
Doses and duration vary by infection type, site, and companion drugs, and kidney or liver problems may require dosing adjustments or extra monitoring. Because rifampin has many drug interactions, the prescriber may modify doses of other medicines or choose alternatives. When patients transition from IV to oral therapy, the total daily dose is generally kept equivalent if possible.

Missed-dose guidance
If a dose is missed, it should usually be given as soon as remembered the same day unless it is close to the time for the next dose; patients should not double up doses without professional advice and should contact their healthcare team if more than one dose has been missed.

Overdose
Suspected overdose (for example, very high dose received or multiple doses close together) can cause serious symptoms such as marked orange discoloration of skin, confusion, severe nausea and vomiting, and liver injury, and requires immediate medical attention or contact with a poison control center.

Common side effects
Common effects include orange-red discoloration of urine, sweat, tears, and other body fluids, mild nausea, abdominal discomfort, diarrhea, headache, and fatigue; these often start in the first days of therapy and are usually mild to moderate.

Serious or rare adverse effects
Serious problems can include liver injury (hepatitis), severe allergic reactions, flu-like syndrome with high fever and muscle aches, low blood counts, kidney problems, and severe skin reactions; warning signs such as yellowing of the skin or eyes, dark urine, persistent nausea or vomiting, severe rash, trouble breathing, or confusion need urgent medical care.

Warnings and precautions
Rifampin must be used cautiously in people with existing liver disease, heavy alcohol use, or those taking other liver-toxic drugs, often with regular blood tests to monitor liver function. It can reduce the effectiveness of many other medicines (for example, warfarin, some HIV drugs, many birth control pills), so dose adjustments or alternative therapies are often needed. In pregnancy, rifampin is generally used when benefits outweigh risks, including for tuberculosis; vitamin K supplementation may be considered near delivery. Rifampin passes into breast milk in small amounts and is usually considered compatible with breastfeeding for tuberculosis treatment, with monitoring as advised by the clinician. Pediatric and older adult patients may need closer monitoring for liver effects and drug interactions.

Comparative safety
Compared with other tuberculosis drugs, rifampin is strongly enzyme-inducing and therefore has more drug–drug interactions, but its liver and allergic risks are broadly similar in magnitude to other first-line TB agents when monitored properly.

Side-effect reporting and safety updates
Patients in the United States can report suspected side effects to the FDA MedWatch program and should check official medication guides or FDA safety communications, or ask their healthcare team or pharmacist, for the latest safety updates.

Drug and supplement interactions
Rifampin is a strong inducer of liver enzymes and can significantly lower blood levels and effects of many drugs, including warfarin and other blood thinners, many HIV antiretrovirals, some antifungals, certain blood pressure and heart medicines, seizure medications, some antidepressants, steroid medicines, and many hormonal contraceptives. It can also interact with some over-the-counter drugs and herbal supplements, such as St. John’s wort, further increasing interaction risk.

Food, alcohol, and other interactions
Food has less impact on IV rifampin absorption than on oral forms, but alcohol increases the risk of liver problems and is generally discouraged or limited. Rifampin can interfere with some laboratory tests by altering liver function results or other measurements; clinicians and laboratories should be informed that the patient is receiving rifampin.

Precautions and conditions making use unsafe or higher risk
Use with caution or avoid in severe liver disease, past rifampin-associated hepatitis, history of severe allergic reaction to rifamycins, or in patients on multiple interacting medicines that cannot be safely adjusted. Careful review of all prescription, OTC, and herbal products is essential before starting therapy.

Monitoring needs
Many patients, especially those with risk factors, have baseline and periodic blood tests for liver function and blood counts. Clinicians may also monitor drug levels or more frequent labs for certain high-risk drug combinations (such as with some HIV medications) and watch closely for signs of liver injury, allergy, or treatment failure.

Q: Why do I need intravenous rifampin instead of pills?
A: IV rifampin is used when you cannot safely swallow or absorb pills, or when your infection is severe enough that your care team wants to ensure reliable dosing through a vein.

Q: How long will I need to be on rifampin?
A: The length of treatment depends on your condition; tuberculosis often requires several months of rifampin as part of a multi-drug regimen, while other serious infections may need weeks to months based on how you respond.

Q: Is it normal for my urine or tears to turn orange while on rifampin?
A: Yes, rifampin commonly turns urine, sweat, saliva, and tears an orange-red color, which is usually harmless but can stain clothing and contact lenses.

Q: Can rifampin affect my birth control?
A: Yes, rifampin can make many hormonal birth control methods less effective, so you may need a non-hormonal or backup method; discuss options with your prescriber before or as soon as you start treatment.

Q: Do I still need other antibiotics if I am getting rifampin?
A: Typically yes; for tuberculosis and many other infections, rifampin is almost always combined with other antibiotics to prevent resistance and improve cure rates, so you should continue all prescribed companion medicines unless your clinician tells you otherwise.

Storage
IV rifampin vials should be stored at room temperature and protected from light as directed on the pharmacy label; once mixed for infusion, they should be used within the time limits specified by the pharmacy and are typically kept under controlled conditions in the clinic or hospital.

Disposal
Any leftover solution or used supplies (tubing, bags, needles) are usually discarded by healthcare staff as medical waste; patients at home should follow infusion-service or pharmacy instructions and return sharps or unused medication through approved take-back or mail-back programs, not in household trash or sinks.